Finance

Lists
42C:SGX
IX Biopharma Ltd
SGD 0.56
+2.78%
(+0.015) 1D
Sep 15, 5:13:17 PM GMT+8  ·   SGD
All symbols
SymbolPriceChange% Change
Generating top insights for 42C...
Open
SGD 0.54
High
SGD 0.56
Low
SGD 0.53
Mkt. cap
606.79M
Avg. vol.
19.59M
Volume
14.54M
52-wk high
SGD 0.62
52-wk low
SGD 0.02
EPS
-SGD 0.01
Shares outstanding
1.09B
No. of employees
35
Open
SGD 0.54
High
SGD 0.56
Low
SGD 0.53
Mkt. cap
606.79M
Avg. vol.
19.59M
Volume
14.54M
52-wk high
SGD 0.62
52-wk low
SGD 0.02
EPS
-SGD 0.01
Shares outstanding
1.09B
No. of employees
35
About IX Biopharma Ltd
CEOEddy Lee
Employees35
Founded2004
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in SGD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SGD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.59M
1.59M
1.59M
2.09M
Cost of goods sold
1.18M
1.18M
983.00K
1.08M
Cost of revenue
1.18M
1.18M
983.00K
1.08M
Research and development expenses
203.00K
203.00K
769.00K
1.31M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.72M
1.72M
1.71M
4.30M
Operating expense
1.94M
1.94M
2.48M
5.63M
Total operating expenses
3.12M
3.12M
3.46M
6.71M
Operating income
-1.53M
-1.53M
-1.87M
-4.62M
Other non operating income
66.00K
66.00K
79.00K
-132.00K
EBT including unusual items
-1.03M
-1.03M
-915.00K
-5.01M
EBT excluding unusual items
-1.03M
-1.03M
-915.00K
-4.65M
Income tax expense
500.00
500.00
1.00K
7.00K
Effective tax rate
-0.05%
-0.05%
-0.11%
-0.14%
Other operating expenses
-
-
-
-
Net income
-1.03M
-1.03M
-916.00K
-5.02M
Net profit margin
-64.76%
-64.76%
-57.65%
-240.35%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-201.50K
-201.50K
-164.00K
-123.00K
Net interest expenses
-201.50K
-201.50K
-164.00K
-123.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.44M
-1.44M
-1.78M
-4.53M
Gain or loss from assets sale
-
-
-
-64.00K
AI content may include mistakes. Learn more
Google apps